Kevin Tsai, MD
Urology · Tacoma, WANPI 1487911236
Payments from drug & device makers
Across 34 payments — averaging $177.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$3K
- Medtronic$2K
- Progenics Pharmaceuticals, Inc.$226
- EDAP Technomed Inc$201
- Intuitive Surgical$186
- Astellas Pharma US Inc$134
- plus $481 from 9 others
What the payments were for
- Consulting fees$1,87531%
- Travel & lodging$2,45241%
- Food & beverage$1,61527%
- Education$982%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 2 | $3,135 |
| Medtronic(2 entities) | 8 | $1,677 |
| Progenics Pharmaceuticals, Inc. | 2 | $226 |
| EDAP Technomed Inc | 1 | $201 |
| Intuitive Surgical | 3 | $186 |
| Astellas Pharma US Inc | 2 | $134 |
| Coloplast | 2 | $123 |
| Procept Biorobotics Corporation | 1 | $93 |
| Urogen Pharma, Inc. | 3 | $55 |
| 180 Medical, Inc. | 2 | $50 |
| Travere Therapeutics, Inc. | 2 | $46 |
| Ferring Pharmaceuticals Inc. | 2 | $38 |
| Dendreon Pharmaceuticals LLC | 1 | $30 |
| Boston Scientific | 2 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,040 in reported general payments places this provider in the 75th percentile of 274 urology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 239 | $3,122 |
| Finasteride | 163 | $2,385 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 11 | $328 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $244 |
| Oxybutynin Chloride ErOxybutynin Chloride | 23 | $223 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 53 | $145 |
| Oxybutynin Chloride | 20 | $126 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 23 | $83 |
| Ciprofloxacin Hcl | 23 | $28 |
Paid to pharmacies, not to this prescriber.
Other urology in Tacoma
- Douglas SutherlandTacoma$15K
- Timothy BrandTacoma$11K
- Carolyn SalterTacoma$8K
- Francis KimTacoma$7K
- James PorterSeattle$2.6M
- Shane PearceSpokane$1.8M
- Raymond LanceSpokane$1.2M
- Jonathan WrightSeattle$1M
- Thomas WalshSeattle$388K
- Una LeeSeattle$236K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.